Meghan Trainor seeks medical help over pain from mysterious burning tongue syndrome: 'A little concerned'
The pop star opened up on a new episode of the Workin' On It podcast that she recently sought medical help for a mysterious condition called burning tongue syndrome, after she experienced sustained pain on the tip of her tongue with no apparent cause.
"I'm sick. Yet again. But, I'm not on antibiotics, I'm going to fight it," 31-year-old said at the top of the show, indicating she was also battling a cold that passed through her home, from her husband, Daryl Sabara, to their son, Barry.
She later explained that her "tongue is still burning" for an unknown reason, and that she went to a dentist to help her.
"If anyone knows why my tip of my tongue is burning with no white patches or anything — you can barely see anything," the "All About That Bass" singer said, indicating that the dentist told her of the condition.
She added that she's been "doing the mouthwash more than four times a day" to find relief, but it's not working.
"You do it as needed it's not helping. It's not working. I'm on day three. She goes, 'My last patient said after two swishes, she was fine, so you'll heal right up,'" Trainor recalled. "I'm like, I'm on day three, so when's the healing right up gonna happen?"
She also told the audience that she's "a little concerned" and "a little worried" at her tongue's lack of progress on the matter.
While the Mayo Clinic doesn't specifically list a disorder called burning tongue syndrome, it does highlight another called burning mouth syndrome. The organization describes it as "ongoing or recurring burning in the mouth without an obvious cause" on the "tongue, gums, lips, inside of your cheeks, roof of your mouth or large areas of your whole mouth." It also notes that the pain is comparable to a feeling "as if you injured your mouth with a very hot drink."
Trainor said that she's treading carefully, as she's not sure why she's enduring difficulties with health conditions as of late.
"I'm having a great time in life other than this. My body's just mad at me and I don't know why," she said. "I'm so tired. I'm trying everything. I'm gluten free, I'm dairy free, I'm egg yolk free."
She finished by saying, "I'm like, I feel incredible, but my immune system does not feel incredible."
Trainor also previously shared details of her home life with Sabara on Dax Shepard's Armchair Expert podcast in 2024, telling the host that the couple share a peculiar two-toilet space in their bathroom, but that she planned on improving it when they moved to a new home.'We're moving into a new house, and it has a toilet facing this way, and a bidet across from it,' she said at the time. 'So I need to make this [bidet] a toilet. So it's gonna be a little different, but it's a tighter bathroom area, so we will be close. Knees to knees.'
Watch Trainor discuss burning tongue syndrome in the podcast video above.
Read the original article on Entertainment Weekly
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025
Conference Call 8:00am ET, Wednesday August 20, 2025 WILMINGTON, Del., Aug. 13, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will release its second quarter 2025 financial results after the market closes on Tuesday, August 19, 2025 via press release, which will be available on the Company's website at The Company will host a conference call the following morning at 8:00am ET, Wednesday August 20, 2025. The Company requires additional time to compile certain information, including recent developments, into the Form 10-Q necessary for a complete presentation, which it is unable to complete without unreasonable effort. A live webcast of the conference call will be available on the Company's website at Participants that are unable to join the webcast can access the conference call via telephone by dialing domestically +1-800-717-1738 or internationally +1-646-307-1865. About NRx Pharmaceuticals, Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. The Company is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRx has recently filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner's National Priority Voucher Program for the treatment of suicidal depression. The filing is based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and the Government of France, licensed under a data sharing agreement. Notice Regarding Forward-Looking StatementsThe information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. The Company has reported regulatory milestones as they have been achieved but has not predicted the outcome of any future regulatory determination. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, including uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy, and, among other things, liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at Except as may be required by applicable law, the Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise. For further information: Matthew Duffy Brian Korb Co-CEO, Hope Therapeutics, Inc. Managing Partner, astr Partners Chief Business Officer, NRx Pharmaceuticals, Inc. (917) 653-5122 mduffy@ View original content to download multimedia: SOURCE NRx Pharmaceuticals, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CBS News
24 minutes ago
- CBS News
Keller: Are Americans going dry? Why there's some benefits to responsible drinking
A new Gallup poll finds the percent of American adults who say they drink alcohol has dropped its lowest point in nearly a century. But while health issues are driving some of the decline, we spoke with two experts who say there are risks to abstaining as well. The 54% who said they drink even sparingly is down from the record highs in the 70s of 50 years ago. When drinking gets out of control, it's a given that trouble can follow. And the Gallup poll shows the decline in drinking is tied to mounting concerns over its impact on health, especially among young adults. But there's another, more positive side to responsible drinking - the social and cultural benefits of bonding with others "where everybody knows your name." "It just makes people feel part of something, and when that gets lost people feel a little isolated," said Maureen Nuccitelli of Watertown, a former bartender turned wellness coach. She said modestly-relaxed inhibitions and the company of friendly others can be a key part of a well-balanced lifestyle. "Sharing a few laughs really helps people lower their stress response and release some of those feelgood hormones and chemicals." The poll suggests at least some young adults may be eschewing alcohol in favor of marijuana. But British drinking culture expert Jane Peyton, founder of the online School of Booze, said, "If you're smoking a joint or if you're eating a gummy, you don't cheers anybody first before you do it." Peyton said it's no surprise that socializing via phone or social media and using marijuana don't provide the bonding experience that responsible alcohol use can. "We need somewhere that we can go as a community or go in a group, be with other people, and a bar or a pub is a perfect place to do that," said Peyton. In fact, said Peyton, in pub culture, the alcohol is beside the point. "If you just drink it moderately and enjoy it, you get the best out of it. So the thing to do with alcohol is get the best out of alcohol and don't let it get the best out of you." Will drinking fade away like cigarette smoking did, now practiced by less than 12% of the population? That's hard to believe, given that it's been a habit for more than 13,000 years and remains the second-most popular drug in the world, trailing only caffeine. It was telling that churches, schools, even public parks were shut down when COVID hit, but not the liquor stores. The question brings to mind a famous polka song that may offer an answer: "In heaven there is no beer/That's why we drink it here."
Wall Street Journal
24 minutes ago
- Wall Street Journal
Genesis Creditors Accuse Nursing Home Owner of ‘Rinse and Repeat' Bankruptcies
Personal-injury claimants alleged that bankrupt nursing home chain Genesis Healthcare is trying to cleanse itself of tort liabilities in chapter 11 before its private-equity investor who controls Genesis buys the company's assets back on the cheap. In recent court filings, lawyers for tort claimants alleged that healthcare and real-estate investor Joel Landau who controls Genesis and other company insiders are attempting to use a $30 million proposed loan to control the chapter 11 process and buy its 175 skilled nursing facilities out of bankruptcy free and clear of past liabilities.
